Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 164
Filtrar
1.
Lett Appl Microbiol ; 73(3): 300-307, 2021 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-34042204

RESUMO

Miscanthus sinensis growing in our study mine site contained a high concentration of Al in the adventitious roots. It has a root endophyte, Phialocephala fortinii, in its adventitious roots at a high frequency. The purpose of this study was to elucidate the effects of P. fortinii on Al tolerance mechanisms of M. sinensis and reveal potential underlying mechanisms. In the absence of P. fortinii, M. sinensis produced chlorogenic, citric, and malic acids that could act to alleviate Al toxicity in acidic mine soil. Up on fungal inoculation, the levels of these compounds were reduced, although the growth of seedlings and Mg concentration in the roots were increased. IAA production by the fungus may contribute to enhanced plant growth whereas an increase of Mg uptake could reduce toxicity of reactive oxygen species under Al stress. These actions of P. fortinii could promote growth and survival of M. sinensis in mine sites.


Assuntos
Alumínio , Solo , Alumínio/toxicidade , Ascomicetos , Raízes de Plantas , Poaceae
2.
Radiat Prot Dosimetry ; 184(3-4): 385-387, 2019 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-31038705

RESUMO

Some microorganisms in the environment make siderophores, which are low molecular chelators, to take up minerals from soil. Eleven bacteria were separated from the root of white clover by chlome azrol S (CAS) assay. Each bacterium was incubated in casamino acid (CAA) culture, and siderophores in CAA culture were purified. These extractions were applied to biotite or vermiculite spiked with Cs. From each clay mineral, 57.1-72.8% (5100 ppm), 55.6-63.8% (920 ppm) and 48.6-54.3% (2300 ppm), 31.6-34.4% (520 ppm) was eluted, respectively. To understand elution behaviour, Cs desorption ratio of each clay was measured every 30 min. The results indicate Cs elution was occurred quickly.


Assuntos
Bactérias/metabolismo , Radioisótopos de Césio/análise , Argila/química , Minerais/análise , Microbiologia do Solo , Poluentes Radioativos do Solo/análise , Silicatos de Alumínio/química , Argila/microbiologia , Compostos Ferrosos/química , Medicago/microbiologia , Raízes de Plantas/microbiologia , Sideróforos/metabolismo
3.
Phys Chem Chem Phys ; 21(13): 7183-7195, 2019 Mar 27.
Artigo em Inglês | MEDLINE | ID: mdl-30888381

RESUMO

Cathode materials with highly reactive surfaces and long-term stability are required to achieve high-performance solid oxide fuel cells (SOFCs). In this study, a promising cathode material, La0.6Sr0.4Co0.2Fe0.8O3-δ (LSCF), was prepared as a nanostructured thin film using pulsed laser deposition (PLD) on gadolinia-doped ceria (GDC)-buffered YSZ single crystal substrates having (100) and (111) orientations. Characterization revealed intrinsic differences among the as-grown LSCF thin films in terms of dominant crystalline orientation and nanostructure depending on GDC preparation as well as the YSZ substrate orientation. Evaluation of the oxygen exchange properties using the isotope exchange depth profile method revealed that LSCF thin films grown on (111) GDC/YSZ exhibited higher values of the apparent surface exchange coefficient compared to LSCF thin films grown on (100) GDC/YSZ. However, when subjected to long-term annealing at high temperatures, the former exhibited a stronger tendency to surface segregation as compared to the latter. These behaviors are correlated with the intrinsic properties of LSCF thin films, including the nanostructure, the possible effects attributed to SrO activity, and the stability of perovskite surfaces which would drive surface segregation. These results have implications for tailoring the performance of cathode thin films by understanding the dependence of oxygen exchange properties and surface segregation on driving forces such as surface chemistry and nanostructure.

4.
J Dairy Sci ; 101(6): 4830-4841, 2018 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-29573807

RESUMO

In a preliminary open-label trial by our group, Bifidobacterium bifidum YIT 10347 (YIT10347) relieved gastric symptoms in patients with functional gastrointestinal disorders. Hence, in this study, we investigated the effects of YIT10347 on gastrointestinal symptoms in healthy adults. In this prospective double-blind, randomized, placebo-controlled trial (UMIN000024654), 100 healthy Japanese adults were randomly assigned to a YIT10347 group or placebo group and consumed 100 mL of YIT10347-fermented milk or placebo fermented milk, respectively, every day for 4 wk. Gastrointestinal symptoms were evaluated by using the modified Frequency Scale for Symptoms of Gastroesophageal Reflux Disease (m-FSSG) and Gastrointestinal Symptom Rating Scale (GSRS) as primary endpoints. Mental symptoms, quality of life, salivary stress markers, and gastric emptying were evaluated as secondary endpoints. Effectiveness and safety were analyzed in a per-protocol set (YIT10347 group, n = 39; placebo group, n = 40) and full analysis set (YIT10347 group, n = 50; placebo group, n = 50), respectively. In the m-FSSG evaluation, the YIT10347 group had a significantly higher relief rate of postprandial discomfort and greater changes in postprandial epigastric pain score from baseline than the placebo group. In the GSRS evaluation, the YIT10347 group had significantly higher relief rates of overall gastrointestinal symptoms, upper gastrointestinal symptoms, flatus, and diarrhea than the placebo group. We detected no significant differences in scores or relief rates of mental symptoms and quality of life, a salivary stress marker, or gastric emptying between the 2 groups. No severe adverse events associated with test beverage consumption were observed in either group. These findings suggest that daily consumption of YIT10347-fermented milk exerts beneficial effects on gastrointestinal discomfort and symptoms such as postprandial discomfort and epigastric pain in healthy adults.


Assuntos
Bifidobacterium bifidum/metabolismo , Produtos Fermentados do Leite/microbiologia , Gastroenteropatias/tratamento farmacológico , Probióticos/administração & dosagem , Adulto , Animais , Produtos Fermentados do Leite/análise , Método Duplo-Cego , Feminino , Fermentação , Esvaziamento Gástrico/efeitos dos fármacos , Gastroenteropatias/dietoterapia , Gastroenteropatias/fisiopatologia , Humanos , Japão , Masculino , Pessoa de Meia-Idade , Leite/metabolismo , Leite/microbiologia , Estudos Prospectivos , Qualidade de Vida , Adulto Jovem
5.
Allergy ; 71(3): 421-5, 2016 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-26551325

RESUMO

Recent studies revealed that Amblyomma or Ixodes tick bites may cause red meat allergy, in which galactose-α-1,3-galactose (α-Gal) is a major IgE-binding epitope. The incidence of red meat allergy is high in Shimane Prefecture, as is tick-transmitted Japanese spotted fever. Therefore, we speculated that tick bites may cause these meat allergies. The carbohydrate α-Gal was detected in the salivary gland protein of Haemaphysalis longicornis (H. longicornis), the vector for Japanese spotted fever, by immunoblotting using anti-α-Gal antibody. H. longicornis salivary gland protein-specific IgE was detected in the sera of 24 of 30 patients with red meat allergies. Sensitization to tick salivary gland protein containing α-Gal is possibly a major etiology of red meat allergy; the carbohydrate plays a crucial role in its allergenicity. These results further indicate that the α-Gal epitope is present not only in Amblyomma or Ixodes, but also in Haemaphysalis.


Assuntos
Alérgenos/imunologia , Hipersensibilidade Alimentar/epidemiologia , Hipersensibilidade Alimentar/etiologia , Ixodes , Carne Vermelha/efeitos adversos , Picadas de Carrapatos , Adulto , Idoso , Idoso de 80 Anos ou mais , Animais , Feminino , Hipersensibilidade Alimentar/diagnóstico , Galactose/imunologia , Geografia , Humanos , Imunoglobulina E/imunologia , Japão/epidemiologia , Masculino , Pessoa de Meia-Idade
6.
J Anim Sci ; 93(6): 2778-84, 2015 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-26115265

RESUMO

The hyperinsulinemic-euglycemic clamp (EGC) technique was used to investigate the effects of calcium salts of long-chain fatty acids (LCFA-Ca) and rumen-protected Met (RPM) on insulin sensitivity in the peripheral tissues of lactating cows. Six multiparous Holstein cows were used in a 3 × 3 Latin square experiment in each 14-d period. Dietary treatments were 0 (RPM0), 20 (RPM20), and 60 (RPM60) g/d of RPM, supplemented with a diet containing 1.5% of LCFA-Ca equal to 110% of the cows' ME requirement. And as a control for the 3 LCFA-Ca-containing diets, a dietary treatment without LCFA-Ca (Con) was also included. After a 10-d adaptation period, milk samples were collected for 4 d, and EGC experiments were performed on d 14 of each treatment period. Insulin solution was infused through a jugular vein catheter at a rate of 0.1, 0.2, 0.3, and 0.4 milliunits·kg BW-1·min-1 for 30 min and then at a rate of 0.5 milliunits·kg BW-1·min-1 for 60 min. Glucose solution was variably infused to maintain plasma glucose at steady state through the same catheter. Blood samples for measurements were taken using the contralateral catheter. Plasma total cholesterol, cholesterol ester, free cholesterol, and phospholipid concentrations in RPM0 and RPM20 were higher than those in Con, whereas the concentrations in RPM60 were low at the same degree of those in RPM0 (P < 0.05). Plasma Met concentration was greatest in RPM60 (P < 0.05). In the EGC experiment, the glucose infusion rate was greater in RPM60 than in RPM0 and RPM20 and an effective concentration of insulin resulting in 50% maximal glucose infusion rate was lower in RPM60 compared with RPM0 (P < 0.05), indicating that insulin sensitivity was intensified in RPM60. Although the insulin sensitivity evaluated from the EGC data in RPM0, RPM20, and RPM60 was not different from Con, a slight decline was observed in RPM0 and insulin sensitivity in RPM60 was higher than Con. Our results from the EGC experiment demonstrated that the feeding RPM lead to increased insulin sensitivity, which suggests that dietary Met affects lipid metabolism via insulin action in lactating dairy cows fed a LCFA-Ca-containing diet.


Assuntos
Dieta Hiperlipídica/veterinária , Gorduras na Dieta/farmacologia , Resistência à Insulina/fisiologia , Metabolismo dos Lipídeos/efeitos dos fármacos , Metionina/farmacologia , Animais , Bovinos , Colesterol/sangue , Suplementos Nutricionais , Relação Dose-Resposta a Droga , Ácidos Graxos/metabolismo , Feminino , Glucose/administração & dosagem , Insulina/administração & dosagem , Insulina/sangue , Lactação/fisiologia , Metionina/sangue , Leite/metabolismo , Rúmen/metabolismo
7.
Parasitology ; 139(12): 1553-61, 2012 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-22906745

RESUMO

Eimeria tenella is recognized worldwide as a significant pathogen in the poultry industry. However, a lack of methods for isolating developing schizonts has hindered the use of transcriptome analyses to discover novel and developmentally regulated genes. In the present study, we characterized the long-term successive development of E. tenella in infected chicken caeca and assessed the utility of laser microdissection (LMD) for the isolation of schizont RNA. Developmental stages, including those of the first, second, and third-generation schizonts and gametocytes, were synchronous. Using LMD, only the mature second-generation schizonts were successfully excised from the lamina propria, and non-degraded RNA was purified from the schizonts. E. tenella-specific genes were amplified by reverse transcription polymerase chain reaction (RT-PCR). These results augment our understanding of the E. tenella life cycle, and reveal LMD as a potentially useful tool for gene expression analyses of the intracellular stages of E. tenella.


Assuntos
Ceco/parasitologia , Eimeria tenella/fisiologia , Microdissecção , RNA de Protozoário/isolamento & purificação , Esquizontes/fisiologia , Animais , Galinhas , Eimeria tenella/genética , Estágios do Ciclo de Vida
8.
Diabetologia ; 53(7): 1362-71, 2010 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-20390404

RESUMO

AIMS/HYPOTHESIS: Diabetogenic loci for type 2 diabetes have been mapped to mouse chromosome (Chr) 11 and 14 in the Nagoya-Shibata-Yasuda (NSY) mouse, an animal model of type 2 diabetes. We aimed to obtain direct evidence of these genes on each chromosome and to clarify their function and interaction in conferring susceptibility to type 2 diabetes. METHODS: We established three consomic strains homozygous for diabetogenic NSY-Chr11, NSY-Chr14 or both on the control C3H background (C3H-11(NSY), C3H-14(NSY) and C3H-11(NSY)14(NSY), respectively), and monitored diabetes-related phenotypes longitudinally. The glucokinase gene was sequenced as a positional candidate gene on Chr11. RESULTS: C3H-11(NSY) mice showed hyperglycaemia associated with impaired insulin secretion and age-dependent insulin resistance without obesity. C3H-14(NSY) mice exhibited hyperglycaemia mainly due to insulin resistance, with a slight increase in percentage body fat. C3H-11(NSY)14(NSY) double consomic mice showed marked hyperglycaemia and obesity, which was not observed in single consomic strains. Sequences of the glucokinase gene were allelically variant between NSY and C3H mice. CONCLUSIONS/INTERPRETATION: These data provide direct evidence that Chr11 and Chr14 harbour major susceptibility genes for type 2 diabetes. These two chromosomes interact to cause more severe hyperglycaemia and obesity, which was not observed with the presence of either single chromosome, indicating different modes of gene-gene interaction depending on the phenotype. Marked changes in the phenotypes retained in the consomic strains will facilitate fine mapping and the identification of the responsible genes and their interaction with each other, other genes and environmental factors.


Assuntos
Cromossomos de Mamíferos/genética , Diabetes Mellitus Tipo 2/genética , Animais , Predisposição Genética para Doença/genética , Hiperglicemia/genética , Camundongos , Fenótipo
10.
Diabetologia ; 50(8): 1641-8, 2007 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-17549450

RESUMO

AIMS/HYPOTHESIS: Obesity and fatty liver are commonly associated with type 2 diabetes, but the genetic and functional bases linking fatty liver with obesity and diabetes are largely unknown. Our aim was to investigate the association of fatty liver with obesity and other diabetes-related phenotypes and to define the genetic control of obesity and fatty liver. MATERIALS AND METHODS: We established 306 F2 mice by crossing Nagoya-Shibata-Yasuda (NSY) mice, an animal model of type 2 diabetes, with control C3H mice, and analysed their phenotypes. Whole-genome screening of F2 mice was performed to identify the loci responsible for fatty liver and obesity. RESULTS: A strong association of fatty liver with obesity, hyperinsulinaemia and hyperglycaemia was observed in F2 mice. Using whole-genome screening in 306 F2 mice, we mapped a new locus for fatty liver (Fl1n) on chromosome 6 (maximum logarithm of odds score [MLS] 10.0) and one for body weight (Bw1n) on chromosome 7 (MLS 5.1). Fl1n was linked to epididymal fat weight as well as fatty liver, but its effects were opposite in the two tissues in that the NSY allele increased liver fat but decreased epididymal fat, suggesting a role of Fl1n in partitioning of fat mass. The sequence of peroxisome proliferator-activated receptor gamma (Pparg), a candidate for Fl1n, showed allelic variation between NSY and C3H mice. CONCLUSIONS/INTERPRETATION: These data suggest that fatty liver and obesity are phenotypically related but genetically independent. Loci homologous to Fl1n and Bw1n are good candidate genes for susceptibility to fatty liver and obesity in humans.


Assuntos
Diabetes Mellitus Tipo 2/genética , Fígado Gorduroso/genética , Obesidade/genética , Animais , Índice de Massa Corporal , Cromossomos de Mamíferos/genética , Modelos Animais de Doenças , Feminino , Genótipo , Masculino , Camundongos , Camundongos Endogâmicos C3H , Fenótipo , Locos de Características Quantitativas/genética
11.
Clin Nephrol ; 68(6): 401-4, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18184523

RESUMO

UNLABELLED: Although dietary control is recommended to chronic kidney disease (CKD) patients, improvement of compliance and education of outpatients are very difficult. The purposes of the present study are to estimate the dietary intake of sodium (Na) and protein by measuring urinary Na and urea nitrogen (UN) excretion, and to evaluate the efficacy of educational hospitalization. METHODS: 70 patients (41 men and 29 women) with a mean age of 58.7+/-15.8 years participated in the present study. Most patients had chronic kidney disease (CKD, Stage 3 or 4). Patients were hospitalized to learn about their diseases and dietary restrictions for 1 week. Patients were given low salt (less than 6 g/day) and low protein (0.6-1.0 g/standard body weight kg/day) diet. 24-hour urine samples were collected at the start (Day 2) and on completion (Day 7) of hospitalization. Salt and protein intakes were estimated using patients' 24-hour urine samples. RESULTS: Estimated salt intake was significantly decreased on completion of the hospitalization (Day 7) (p < 0.05). Estimated protein intake was also decreased slightly, but this was not statistically significant. There were significant differences in the changes of body weight, body mass index (BMI), and systolic and diastolic blood pressure between the start (Day 2) and completion (Day 7) of hospitalization. 89% of the patients showed an improved blood pressure without changes of antihypertensive drugs. CONCLUSIONS: It appears that short-term hospitalization is an effective program for achieving dietary and blood pressure control in CKD patients.


Assuntos
Proteínas Alimentares , Hospitalização , Nefropatias/terapia , Educação de Pacientes como Assunto , Sódio na Dieta , Adulto , Idoso , Idoso de 80 Anos ou mais , Proteínas Alimentares/administração & dosagem , Feminino , Humanos , Nefropatias/urina , Masculino , Pessoa de Meia-Idade , Sódio na Dieta/administração & dosagem
12.
J Immunol Methods ; 279(1-2): 135-42, 2003 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12969554

RESUMO

BACKGROUND: We have shown that measurement of mRNA for cytotoxic attack proteins perforin and granzyme B in urinary cells is a noninvasive means of diagnosing acute rejection of human renal allografts. Urinary cell mRNA studies have yielded useful information in other patient populations such as patients with cancer. The isolation of sufficient and high quality ribonucleic acid (RNA) from urinary cells however is problematic. RNAlater, an RNA stabilization solution, has been reported to optimize RNA isolation from tumor tissues stored at room temperature and from pigment-rich ocular tissues. METHODS: We explored whether the addition of RNAlater to urine cell pellets improves RNA yield, enhances purity and facilitates measurement of low abundance mRNAs. We measured, with the use of real-time quantitative polymerase chain reaction (PCR) assay, levels of expression of a constitutively expressed gene 18S rRNA and mRNA for granzyme B and transforming growth factor-beta(1) (TGF-beta(1)) in urine specimens and renal biopsies obtained from renal allograft recipients. RESULTS: RNA yield (P<0.01, Wilcoxon signed rank test) and the A260/A280 ratio (P<0.01) were both higher with urine cell pellets treated with RNAlater prior to snap freezing compared to cell pellets that were not treated with RNAlater prior to snap freezing. Levels (copy number per 1 microg of total RNA) of 18S rRNA (P<0.02), granzyme B mRNA (P=0.002) and TGF-beta(1) (P=0.02) were all higher with treated urine cell pellets compared to untreated cell pellets. Kruskall-Wallis one way analysis of variance and pair-wise comparisons with Student-Newman-Keuls test showed that the levels of mRNA for granzyme B (P<0.05) and TGF-beta(1) (P<0.05) are significantly different between renal allograft biopsies and untreated urine cell pellets but not between the biopsy specimens and RNAlater-treated urine cell pellets. CONCLUSIONS: The addition of RNAlater to urine cell pellets improves RNA isolation from urinary cells and facilitates measurement of low abundance mRNAs.


Assuntos
RNA/isolamento & purificação , Urina/citologia , Adolescente , Criança , Granzimas , Humanos , RNA/análise , RNA/urina , RNA Ribossômico 18S/urina , Serina Endopeptidases/genética , Espectrofotometria , Fator de Crescimento Transformador beta/genética
13.
Clin Exp Immunol ; 133(1): 59-66, 2003 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12823279

RESUMO

To investigate age-related alterations in human humoral immunity, we analysed Ig heavy chain variable region genes expressed by peripheral B cells from young and aged individuals. Three hundred and twenty-seven cDNA sequences, 163 micro and 164 gamma transcripts with VH5 family genes, were analysed for somatic hypermutation and VHDJH recombinational features. Unmutated and mutated micro transcripts were interpreted as being from naive and memory IgM B cells, respectively. In young and aged individuals, the percentages of naive IgM among total micro transcripts were 39% and 42%, respectively. D and JH segment usage in naive IgM from aged individuals was similar to that from young individuals. The mutational frequencies of memory IgM were similar in young and aged individuals. gamma transcripts, which are regarded as being from memory IgG B cells, showed a significantly higher mutational frequency (7.6%) in aged than in young individuals (5.8%) (P < 0.01). These findings suggest that VHDJH recombinational diversity was preserved, but that the accumulation of somatic mutations in the IgG VH region was increased in aged humans. The accumulation of somatic mutations in IgG B cells during ageing may imply that an age-related alteration exists in the selection and/or maintenance of peripheral memory B cells.


Assuntos
Envelhecimento/imunologia , Linfócitos B/imunologia , Região Variável de Imunoglobulina/genética , Adulto , Idoso , Idoso de 80 Anos ou mais , Formação de Anticorpos/genética , Distribuição de Qui-Quadrado , Análise Mutacional de DNA , Feminino , Humanos , Região de Junção de Imunoglobulinas , Imunoglobulina M , Memória Imunológica , Masculino
14.
Ther Apher ; 6(2): 154-8, 2002 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11982957

RESUMO

This study was performed to examine the effects of intravenous human immunoglobulin (IVIG) on the level of serum immunoglobulin G (IgG) and its subclasses after plasmapheresis in patients with autoimmune disorders. Twenty-nine patients with predominantly rheumatoid arthritis were enrolled in this study. The plasmapheresis was performed by the use of double-filtration plasmapheresis (DFPP). Immediately after DFPP, IVIG (2.5 g, 50 ml) was intravenously administered. The treatment with IVIG had almost no effect on subjective and objective symptoms. Immediately after DFPP, the total of serum IgG was decreased by approximately 40%. After 24 h, the total of serum IgG recovered to 16% reduction in IVIG-treated patients whereas it remained at 32% reduction in nontreated patients. The beneficial effect of IVIG was significantly observed in patients who had shown 1,000-1,800 mg/dl IgG in their sera. After DFPP, IgG subclasses were decreased without change in the ratio of subclasses. Twenty percent to 30% of IgG subclasses were supplemented by the treatment with IVIG without change in the ratio of subclasses. These results suggested that the treatment with IVIG at minimal amount was safe and effective to supplement IgG for hypogammaglobulinemia after DFPP.


Assuntos
Artrite Reumatoide/terapia , Imunoglobulina G/sangue , Imunoglobulinas Intravenosas/uso terapêutico , Plasmaferese , Adulto , Agamaglobulinemia/prevenção & controle , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade
15.
Cardiology ; 96(1): 16-23, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11701936

RESUMO

AIMS: In this study, we investigated the clinical usefulness of ultrasonic tissue characterization with integrated backscatter for the evaluation of myocardial histological abnormalities in comparison with endomyocardial biopsy findings in patients with hypertrophic cardiomyopathy. METHODS: Twenty patients with hypertrophic cardiomyopathy and 20 normal subjects were enrolled in this study. We measured two parameters for the ultrasonic tissue characterization with integrated backscatter: the magnitude of the cardiac-cycle-dependent variation in integrated backscatter signals (cdv-IB) and the mean value of integrated backscatter signals calibrated by the pericardium (cal-IB). These parameters were measured at both the interventricular septum and the left ventricular posterior wall. Histological findings of right ventricular endomyocardial biopsy specimens were analyzed by computer image analyzer. RESULTS: cdv-IB was significantly lower and cal-IB significantly higher in both the interventricular septum and the left ventricular posterior wall in patients with hypertrophic cardiomyopathy compared with normal subjects. In patients with hypertrophic cardiomyopathy, the degree of myocardial disarray, interstitial fibrosis, and nonhomogeneity of myocyte size showed positive correlations with cal-IB and negative correlations with cdv-IB. CONCLUSIONS: Ultrasonic tissue characterization with IB enables the noninvasive evaluation of myocardial histological abnormalities in patients with hypertrophic cardiomyopathy.


Assuntos
Cardiomiopatia Hipertrófica/diagnóstico por imagem , Anormalidades Cardiovasculares/diagnóstico por imagem , Miocárdio/ultraestrutura , Adulto , Idoso , Biópsia , Cardiomiopatia Hipertrófica/patologia , Anormalidades Cardiovasculares/patologia , Ecocardiografia , Feminino , Septos Cardíacos/citologia , Septos Cardíacos/diagnóstico por imagem , Septos Cardíacos/patologia , Ventrículos do Coração/citologia , Ventrículos do Coração/diagnóstico por imagem , Ventrículos do Coração/patologia , Humanos , Masculino , Pessoa de Meia-Idade , Miocárdio/citologia , Miocárdio/patologia , Reprodutibilidade dos Testes
16.
Ther Apher ; 5(4): 287-92, 2001 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-11724514

RESUMO

Cytapheresis has been investigated recently for the treatment of autoimmune related diseases, such as rheumatoid arthritis (RA), inflammatory bowel disease (IBD), multiple sclerosis, and so on. A large number of physicians have indicated that patients with autoimmune diseases respond to cytapheresis treatment. The effective mechanism of cytapheresis for immune disorders is still controversial. However, the removal of the leukocyte including granulocyte, lymphocyte, and monocyte may play a crucial role in correcting imbalance of the immune system. A session of cytapheresis including leukocytapheresis (LCAP) and granulocytapheresis (GCAP) may not create a sufficient amount of cell removal for the human body. However, the cell removal can be a trigger of the immunomodulation as the treatment for immune disorder. Furthermore, not only cell removal but also reaction by blood contacting with medical device materials may play a role as an immunomodulation for immune disorders. This review introduces current cytapheresis technologies and attempts to elucidate the effective mechanism of cytapheresis for immune disorders, focused on LCAP and/or GCAP for RA or IBD.


Assuntos
Artrite Reumatoide/terapia , Citaferese , Doenças Inflamatórias Intestinais/terapia , Citaferese/métodos , Granulócitos , Humanos , Leucaférese
17.
AIDS Res Hum Retroviruses ; 17(16): 1507-15, 2001 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-11709095

RESUMO

HIV-1 infection results in a gradual decrease in CD4(+) T cell counts and progressive immune deficiency. Increased T cell turnover in HIV-1-infected patients, which can be interpreted as T cell clonal expansion, has been thought to be relevant to its pathogenesis. To investigate whether B cell clonal expansion also occurs in HIV-1-infected patients, we examined the expressed V(H)DJ(H) gene sequences of peripheral B cells in HIV-1-infected patients with hypergammaglobulinemia. Identical V(H)DJ(H) gene rearrangements with additional nucleotide differences in V(H) genes were analyzed as a marker of clonally related B cells. From healthy individuals and HIV-1-uninfected patients with hypergammaglobulinemia, clonally related B cells were detected in none of 10 (0%) and 2 of 10 (20%), respectively. No clonally related B cells were detected in any of the nine HIV-1-infected patients with detectable viral loads and normal Ig levels (0%). In contrast, from 9 of 14 HIV-1-infected patients with hypergammaglobulinemia (64%), clonally related B cells were detected. In addition, no HIV-1-infected patients who exhibited normal Ig levels after antiretroviral therapy had clonally related B cells. These findings suggest that B cell clonal expansion is present in HIV-1-infected patients with hypergammaglobulinemia.


Assuntos
Linfócitos B/imunologia , Infecções por HIV/complicações , HIV-1/imunologia , Hipergamaglobulinemia/imunologia , Ativação Linfocitária/imunologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Fármacos Anti-HIV/uso terapêutico , Sequência de Bases , Feminino , Rearranjo Gênico do Linfócito B/genética , Genes de Imunoglobulinas/genética , Infecções por HIV/tratamento farmacológico , Humanos , Cadeias Pesadas de Imunoglobulinas/genética , Masculino , Pessoa de Meia-Idade , Análise de Sequência de DNA
18.
Ryumachi ; 41(4): 726-35, 2001 Aug.
Artigo em Japonês | MEDLINE | ID: mdl-11577401

RESUMO

OBJECTIVES: Neonatal lupus erythematosus is characterized by transient lupus abnormalities, various systemic and hematological abnormalities, and congenital complete heart block (CCHB). It is well known that anti-SS-A/Ro antibody (52 kD/60 kD) and anti-SS-B/La antibody are associated with CCHB. This study was conducted to evaluate the effects of the removal of anti-SS-A/Ro antibody (52 kD/60 kD) and anti-SS-B/La antibody from plasma in pregnant women whose fetuses are at a high risk of developing CCHB. MATERIALS & METHODS: Fifteen pregnant patients positive for anti-SS-A/Ro antibody and anti-SS-B/Laantibody were subjected weekly to double filtration plasmapheresis to remove both antibodies. Antibody titers were measured by double immunodiffusion (DID) and ELISA. RESULTS: As a result, all women gave birth to live babies, but CCHB was recognized in one baby. No transient lupus abnormalities were recognized in any of the babies. Fourteen patients showed decreased antibody titers by ELISA during plasmapheresis. However, the patient who was delivered of a baby with CCHB showed an increase of antibody titers by ELISA while the DID method showed a decrease of antibody titers. CONCLUSION: Our study suggested that plasmapheresis prevents CCHB associated with anti-SS-A/Ro and anti-SS-B/La antibody. Also, it is important to monitor the antibody titer regularly during the course of pregnancy, because it may increase due to worsening of the mother's primary disease.


Assuntos
Anticorpos Antinucleares/imunologia , Bloqueio Cardíaco/congênito , Bloqueio Cardíaco/prevenção & controle , Plasmaferese , Gravidez/imunologia , Adulto , Feminino , Humanos
19.
J Nat Prod ; 64(7): 932-4, 2001 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-11473426

RESUMO

Two new cuparene-type sesquiterpenes, enokipodins C (1) and D (2), were isolated from culture medium of an edible mushroom, Flammulina velutipes, along with enokipodins A (3) and B (4). The structures of 1 and 2 were determined using spectroscopic methods (HRMS, (1)H and (13)C, and 2D NMR). The absolute configuration of enokipodin C was determined from the observed (1)H NMR chemical shifts and NOEs in NOESY experiments after conversion into the corresponding esters with the chiral reagent 2-(2'-methoxy-1'-naphthyl)-3,4-dichlorobenzoic acid. All the metabolites showed antimicrobial activity against a fungus, Cladosporium herbarum, and Gram-positive bacteria, Bacillus subtilis and Staphylococcus aureus.


Assuntos
Antifúngicos/isolamento & purificação , Basidiomycota/química , Sesquiterpenos/isolamento & purificação , Antifúngicos/química , Antifúngicos/farmacologia , Bacillus subtilis/efeitos dos fármacos , Clorobenzoatos/química , Cladosporium/efeitos dos fármacos , Escherichia coli/efeitos dos fármacos , Japão , Pseudomonas fluorescens/efeitos dos fármacos , Sesquiterpenos/química , Sesquiterpenos/farmacologia , Staphylococcus aureus/efeitos dos fármacos
20.
J Periodontal Res ; 36(3): 175-82, 2001 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-11453116

RESUMO

This study was designed to examine the effect of aging on bone formation induced by recombinant human bone morphogenetic protein-2 (rhBMP-2) combined with a fibrous collagen membrane (FCM). Implantation was done subperiosteally in bilateral palatal grooves in 34 male Wistar rats divided into three age groups: a 10-week-old group (10w group), a 30-week-old group (30w group) and a 70-week-old group (70w group). RhBMP-2-combined FCMs were implanted on the left palatal grooves as BMP-implanted sites (BMP site), while rhBMP-2 was not implanted on the right palatal grooves as control sites. The rats were sacrificed 6 weeks after implantation, and histometric evaluations were performed. New bone formation was observed in every site of each age group and the new bone was almost completely continuous with the original bone. The new bone volume (NBV) of the BMP site was significantly higher than that of the control site in each age group. The NBV of both the control and BMP sites were highest in the 10w group and lowest in the 70w group. The disparity of NBV between the control and BMP sites, which indicated the response to implanted BMP excluding the effect of skeletal growth and surgical stimulation, did not significantly differ among the age groups. These results indicate that rhBMP-2-combined FCM has the ability to induce new bone formation continuous with original bone even in senescent rats. Furthermore, it appeared that, in the case of palatal subperiosteal implantation, the responsiveness to implanted BMP was independent of age, although the total volume of newly formed bone declined with aging.


Assuntos
Envelhecimento/fisiologia , Proteínas Morfogenéticas Ósseas/uso terapêutico , Colágeno , Membranas Artificiais , Osteogênese/efeitos dos fármacos , Palato/efeitos dos fármacos , Próteses e Implantes , Fator de Crescimento Transformador beta/uso terapêutico , Animais , Peso Corporal , Proteína Morfogenética Óssea 2 , Proteínas Morfogenéticas Ósseas/administração & dosagem , Portadores de Fármacos , Seguimentos , Humanos , Masculino , Osteócitos/patologia , Osteogênese/fisiologia , Palato/patologia , Palato/cirurgia , Periósteo/efeitos dos fármacos , Periósteo/patologia , Periósteo/cirurgia , Ratos , Ratos Wistar , Proteínas Recombinantes , Estatísticas não Paramétricas , Fator de Crescimento Transformador beta/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...